FDA to hold patient meeting on opioid use disorder

FDA is asking individuals with opioid use disorder to testify at a public meeting April 17. The event is part of the agency's Patient Focused Drug Development (PFDD) initiative, which includes a series of public meetings to discuss the effects of diseases on daily life, the measures of benefit that matter most to patients and the adequacy of available treatment options...